Fair Value Measurements (ASC 820) |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||
| Fair Value Disclosures [Abstract] | ||||||||||
| Fair Value Measurements (ASC 820) | (17) Fair Value Measurements (ASC 820)
Fair Value of Financial Instruments The Company evaluates and discloses the fair value of its financial instruments in accordance with ASC 820, Fair Value Measurement and ASC 825, Financial Instruments. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The guidance establishes a three-level hierarchy for fair value measurements based on the observability of inputs:
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value due to their short-term nature.
Investments in Marketable Securities As of December 31, 2025, the Company held restricted, marketable equity securities that are carried at fair value based on Level 1 inputs. These securities are measured at fair value at each reporting date, with unrealized gains and losses recognized in Other Income / (Expense) in the Statement of Operations. The Company’s cost basis in these securities was $25,500, and their fair value as of December 31, 2025, was $51,300. Accordingly, the Company recognized an unrealized gain of $25,800 for the year ended December 31, 2025.
Cash and Cash Equivalents For purposes of the Statements of Cash Flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. |